FDA recently removes the black box warnings on menopausal hormone therapy after 20 years
As of last month, according to the US Department of Health and Human Services, the FDA is requesting that companies remove references to health risks with use like: risk of cardiovascular disease, breast cancer and probable dementia.Β

